Barr Pharmaceuticals, Inc.
New reports from Barr Pharmaceuticals, Inc., detailed
Published in Lab Business Week, July 29th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Barr Pharmaceuticals, Inc.
Report 1: Barr Pharmaceuticals, Inc. (NYSE:BRL) announced that its subsidiary PLIVA has received tentative approval from the U.S. Food and Drug Administration (FDA) for its generic version of Janssen Pharmaceutica Products, L.P.'s Risperdal(R) (Risperidone) Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg.
A tentative approval reflects FDA's determination that a generic product satisfies the requirements for final approval, subject to the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2007-07-29)
More Articles from Lab Business Week
- Abbott Laboratories
Abbott and Government of Brazil Sign Kaletra (lopinavir/ritonavir) Supply Agreement - Auriga Laboratories, Inc.
A.T.S. Pharmaceuticals, a Division of Auriga Laboratories Launches Xyralid RC - Bird Flu
Carrington Subsidiary DelSite Enters Into Consulting Agreement with Biologics Consulting Groups, Inc. - Clinical and Laboratory Standards Institute
New CLSI Guideline Provides Protocols for Laboratory Instrument Implementation, Verification, and Maintenance - Clinical Trial Research
Women's Sexual Health Study Shows Positive Results for Zestra Feminine Arousal Fluid - Congenital Hypothyroidism
New congenital hypothyroidism study results reported from The Jackson Laboratory - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
